Intranasal Diprospan Injection for Chronic Rhinosinusitis Treatment-Two Case ReportsAnna Yu Poghosyan1*, Armen L Zargaryan1 and Levon R Galstyan2
- *Corresponding Author:
- Anna Yu. Poghosyan
Head of ENT and Maxillofacial Surgery
Department in “Heratsy” â1 Hospital 60 Abovyan Str
Yerevan, 0025, Armenia
E-mail: [email protected]
Received Date: April 02, 2016; Accepted Date: April 14, 2016; Published Date: April 20, 2016
Citation: Poghosyan AY, Zargaryan AL, Galstyan LR (2016) Intranasal Diprospan Injection for Chronic Rhinosinusitis Treatment: Two Case Reports. J Orthop Oncol 2:109. doi:10.4172/2472-016X.1000109
Copyright: © 2016 Poghosyan AY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects 0.5–4% of the world population and is present in ∼20% of patients with CRS. There are no definitive guidelines for the treatment of CRS largely due to the lack of consensus on the etiology of the disease. The management of chronic rhinosinusitis with nasal polyps, aimed at improving clinical symptoms, includes both surgical and medical treatments, but there is no universally accepted management protocol. Two case reports of CRSw NP treatment by intranasal Diprospan injection are presents. In both cases significant clinical and radiological improvement was observed without any side effects.